A New Study Explores the Boundary Between Everyday Caffeine and Panic

Why It Matters

The research indicates that moderate caffeine consumption is generally safe for panic‑disorder patients, allowing clinicians to tailor dietary advice rather than enforce total abstinence. It also highlights a potential trade‑off: caffeine may increase avoidance, which could complicate exposure‑based therapies.

Key Takeaways

• 150 mg caffeine (~1.5 cups) did not raise anxiety scores
• Caffeine increased physiological arousal measured by skin conductance
• Both groups showed more avoidance of aversive stimuli after caffeine
• Panic disorder patients already exhibit higher baseline avoidance behavior
• Study suggests moderate coffee is safe for panic disorder patients

Pulse Analysis

Caffeine’s reputation as an anxiety trigger stems largely from studies using extreme doses—four or five cups at once—that reliably provoke panic attacks in susceptible individuals. Those findings have filtered into clinical guidelines, prompting many therapists to advise patients with panic disorder to eliminate coffee entirely. However, everyday coffee consumption typically falls far below that threshold, leaving a knowledge gap about its real‑world impact on panic‑prone populations. The new randomized, placebo‑controlled crossover trial from Uppsala University directly addresses this gap by testing a physiologically realistic 150 mg caffeine dose, comparable to a modest morning brew.

The study enrolled 29 adults diagnosed with panic disorder and 53 healthy controls, all low‑caffeine consumers, and measured three anxiety components: subjective ratings, physiological arousal, and behavioral avoidance. Participants reported no increase in anxiety after caffeine, and only a single panic attack was observed. Physiologically, caffeine elevated skin conductance across both groups, confirming heightened sympathetic activity. Behaviorally, caffeine prompted participants to forgo potential rewards to avoid unpleasant images and sounds, indicating a modest rise in costly avoidance. Notably, the increase was uniform; panic‑disorder patients did not exhibit a disproportionate response, though they started with higher baseline avoidance.

Clinically, the findings suggest that clinicians can relax blanket caffeine bans for panic‑disorder patients, focusing instead on individualized dietary counseling. Therapists should remain aware that caffeine may subtly boost avoidance tendencies, which could interfere with exposure‑based interventions if not monitored. Future research should explore a broader dose range and larger, gender‑balanced samples to pinpoint the exact caffeine threshold where anxiety escalates. Until then, a single cup of coffee appears to pose minimal acute risk for panic attacks while offering the familiar alertness many patients value.